Come discuss the new AASLD EXPO on management of pruritus in genetic cholestatic syndromes with writing group member Dr. Vitola.

Artificial intelligence is affecting many aspects of the field. How does HEPTOLOGY plan to adapt and oversee responsible AI use in research? Come discuss with the new HEPATOLOGY editors, Dr. Chalasani and Dr. Nagy.
 

How do PEth testing and modification of cardiometabolic risk factors impact recompensation of decompensated cirrhosis in MASLD and metALD?  Come discuss with Dr. Reddy, the author of the recent HEPATOLOGY article “Recompensation of decompensated cirrhosis in a spectrum of metabolic dysfunction–related steatotic liver disease, with PEth-corroborated alcohol abstinence and modification of cardiometabolic risk factors.” Read the article here: https://doi.org/10.1097/HEP.0000000000001822
 

Come discuss the science behind the October special issue of HEPATOLOGY, focusing entirely on liver cancer with HEPATOLOGY Associate Editor Dr. Sumera I. Ilyas. Read the issue here: https://journals.lww.com/hep/toc/2024/10001
 

Come discuss the new AASLD EXPO on hepatitis delta virus with writing group member Dr. Feld.

How do different interventions affect medication adherence after liver transplantation? Come discuss with Dr. Lieber an author of the recent Liver Transplantation article “Medication adherence and telehealth interventions after liver transplantation: A systematic review and meta-analysis.” Read the article here: https://doi.org/10.1097/LVT.0000000000000980.
 

I have been working in hepatology at Rush University Medical Center in Chicago since 2015, first as an out patient nurse and now as a nurse practitioner. I studied nursing and religion at St. Olaf college for my bachelors degree and went on to get my DNP from Rush University Medical Center. In my free time I love to hike and travel, I was able to hike Mt. Fuji earlier this year.

Prof Jeffrey V Lazarus (PhD, MIH, MA) is a full professor at the CUNY Graduate School of Public Health and Health Policy and the head of the Public Health Liver Group at ISGlobal, where he is a research professor. His decade-long career at WHO's Regional Office for Europe was followed by serving as the Vice-Chair of the EASL International Liver Foundation, Board Chair of the foundation AFEW International and as the first director of Health Systems Global.

Dr. Evon is a clinical health psychologist, Professor of Medicine in the Division of GI and Hepatology at the University of North Carolina in Chapel Hill since 2005. She is a clinician and behavioral researcher in the field of chronic liver disease for 20 years. Clinically, she works with patients with MASLD/MASH to make lifestyle changes to improve liver health and achieve weight loss and with patients with cirrhosis and other liver diseases on coping, adjustment and self-management. Dr. Evon is also very passionate about patient-centered outcomes research.